<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>THE PREVALENCE OF METALLO-Β-LACTAMASE IMP-7 GENE IN IMIPENEM AND MEROPENEM RESISTANT PSEUDOMONAS AERUGINOSA AMONG PATIENTS WITH DIFFERENT DISEASES IN EL-OBIED HOSPITALS – SUDAN</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Wafaa Mohammed Adam Abdulrahaman</mods:namePart><mods:namePart type="family">Wafaa Mohammed Adam Abdulrahaman</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Rapid spread of MBLs is an emerging threat and a matter of concern worldwide. So far, six MBL enzyme types have been described in clinical isolates of P. aeruginosa. In this article, we investigated the prevalence of Metallo-β-Lactamase IMP- 7 genes in imipenem and meropenem-resistant Pseudomonas aeruginosa isolated from Elobied Hospitals. A hundred (100) isolated Pseudomonas aeruginosa were cultured and identified using API thin subjected to antimicrobial susceptibility testing&amp;nbsp; (Kirby Bauer), for selected imipenem and meropenem. PCR was performed for detection of IMP- 7 gene in imipenem and meropenem resistant P. aeruginosa strains. 19% and 14% isolates were found resistant to imipenem and meropenem respectively, 16 % of isolated resistant P. aeruginosa carry the IMP- 7gene which encoding resistant to imipenem and meropenem in our study. The study concluded that evidence of the presence of the IMP- 7gene.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-07-26</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>